Advanced Micro Devices
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
Track Advanced Micro Devices in real time with a live news feed covering Advanced Micro Devices stock news, official press releases, company announcements, and an archive of historical Advanced Micro Devices news. ...more
Loading news...
Loading more...
7:00 AM | Wednesday | Jun 24, 2026
Sign in to download news snippet
AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced an oversubscribed $330 million Series B financing. The financing round was co-led by new investor TCGX and founding investor ARCH Venture Partners, with participation from a syndicate of leading healthcare-focused crossover investors, sovereign wealth funds and other institutional investors new to Ollin, including a16z Bio.
Read full articleNo data available for this time period.
Change the time range to see results.
AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced an oversubscribed $330 million Series B financing. The financing round was co-led by new investor TCGX and founding investor ARCH Venture Partners, with participation from a syndicate of leading healthcare-focused crossover investors, sovereign wealth funds and other institutional investors new to Ollin, including a16z Bio.
Read full article
New AI-ready mini PC delivers 86 TOPS of local AI performance, 48GB DDR5 memory, OCuLink expansion, and support for up to 96GB RAM and 8TB storage in a compact form factor New AI-ready mini PC delivers 86 TOPS of local AI performance, 48GB DDR5 memory, OCuLink expansion, and support for up to 96GB RAM and 8TB storage in a compact form factor
Read full article
ISELIN, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the U.S.
Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for ONS-5010/LYTENAVA™ for the treatment of neovascular age-related macular degeneration (nAMD), or wet AMD.
SANTA CLARA, Calif. and SAN ANTONIO, June 16, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) and Rackspace Technology® (NASDAQ: RXT), a global enterprise AI infrastructure and solutions provider, today announced the signing of a definitive agreement for the phased deployment of an initial 30 MW footprint dedicated to AMD-based compute deployments across Rackspace's global data centers beginning in late 2026 through 2028.
Read full article
LongPoint expects to launch three ETFs - AMDU, MUU, ORBU New Savvy ETFs provide two times leveraged long exposure to AMD, Micron, and SpaceX LongPoint is a Canadian owned and operated ETF provider Toronto, Ontario--(Newsfile Corp. - June 15, 2026) - LongPoint Asset Management Inc. ("LongPoint") is proud to announce the launch of three new Savvy Double Leveraged Single Stock ETFs on the Toronto Stock Exchange (the "TSX") on Wednesday, June 17, 2026. The SavvyLong (2X) AMD ETF ("AMDU") offers two times leveraged long exposure to Advanced Micro Devices, Inc., the SavvyLong (2X) Micron ETF ("MUU") offers two times leveraged long exposure to Micron Technology, Inc.
, and the SavvyLong (2X) SpaceX ETF ("ORBU") offers two times leveraged long exposure to Space Exploration Technologies Corporation.
LAS VEGAS--(BUSINESS WIRE)--TensorWave, the all-AMD AI cloud specializing in high-performance, memory-intensive workloads, today announced it has raised $350 million in Series B funding. The round was co-led by Magnetar and AMD Ventures, with continued participation from Maverick Silicon, Nexus Venture Partners, and Western Frontier. The new capital will support the expansion of TensorWave's global AI infrastructure footprint, including the deployment of next-generation AMD Instinct™ MI355X GPU.
Read full article
News Highlights: £2bn investment over five years to support advanced computing, scientific research and workforce development across the United Kingdom. New strategic partnerships with Imperial College London and Oriole Networks will help advance AI, quantum and next-generation computing research.
Read full article
Next –generation Supermicro AMD Helios platform to be showcased at Computex Rack-scale DCBBS architecture enables rapid deployment and seamless scaling from single racks to hyperscale AI clusters 72-GPU double-width Helios rack powered by AMD Instinct™ MI455X GPUs delivers exceptional performance for large-scale AI training and inference workloads SAN JOSE, Calif. and TAIPEI, June 2, 2026 /PRNewswire/ -- Super Micro Computer, Inc. (NASDAQ: SMCI), an AI, Enterprise, Storage, 5G/Edge Total Solution Provider featuring Data Center Building Block Solutions® (DCBBS), in close collaboration with AMD, will showcase the next-generation AMD Helios rack-scale platform at Computex.
Read full article
Access to AI Developer Cloud Resources is Expected to be Utilized to Support Modeling of Energy-Efficient Semiconductor Technologies for AI, Defense and Space Applications HOBOKEN, N.J., May 28, 2026 /PRNewswire/ -- Rocket One Inc. ("Rocket One" or the "Company") (NASDAQ: RKTO), a company focused on developing and commercializing next-generation AI semiconductor acceleration and radiation-tolerant computing technologies for defense and space applications, today announced its acceptance into the AMD AI Developer Program operated by Advanced Micro Devices, Inc. The program provides Rocket One with access to AI development resources, potential cloud computing credits, technical training, and developer tools designed to support the development and simulation of advanced AI workloads and accelerator architectures.
AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to provide a one-year integration update following its purchase of AGNES Connect software and related AMD Telemedicine assets. The Company has fully integrated the AMD software and related systems into UniDoc's ecosystem, retained more than 97% of AMD's active clients and added 59 new sites during the last year.
Read full article
No data available for this time period.
Change the time range to see results.